Literature DB >> 28455074

Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature.

M Rizwan Sardar1, Zubair A Khan2, Anu Abraham3, Wajeeha Saeed4, Muhammad Farhan5, Dhaval Kolte4, Barry Sharaf4, Paul Gordon4, Frank Sellke6, Neel R Sodha6, Herbert D Aronow4, Afshin Ehsan7.   

Abstract

Development of membranous ventricular septal defects (VSD) is a rare complication of transcatheter aortic valve replacements (TAVR), and is recognized using intraoperative and postoperative imaging. We present two cases of this rare but serious complication; one was successfully managed conservatively and the other with valve-in-valve therapy. Management strategies for post-TAVR VSDs varies, but should be individualized to the clinical scenario. We performed a literature search and sought to identify various risk factors which may predispose patients to the development of VSD after TAVR.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Transcatheter aortic valve replacement; Ventricular septal defect

Mesh:

Year:  2017        PMID: 28455074     DOI: 10.1016/j.carrev.2017.04.003

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  2 in total

1.  Percutaneous closure of an iatrogenic ventricular septal defect following transcatheter aortic valve implantation.

Authors:  Marc-Alexander Ohlow; Matthias Schreiber; Bernward Lauer
Journal:  J Cardiol Cases       Date:  2017-08-12

2.  More in, better out? Successful valve-in-valve procedure of an iatrogenic ventricular septal defect following transcatheter aortic valve replacement: a case report.

Authors:  Klaus-Dieter Hönemann; Steffen Hofmann; Frank Ritter; Gerold Mönnig
Journal:  Eur Heart J Case Rep       Date:  2021-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.